Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent

<div>Kaplan-Meier survival curves for primary and secondary endpoints in the matched population. BARC, bleeding academic research consortium; DAPT, dual antiplatelet therapy; HR, hazard ratio; MI, myocardial infarction; TVR, target-vessel revascularization. (a) Death, MI, or TVR. (b) Cardiac death or MI. (c) Target vessel revascularization. (d) Bleeding: BARC 2, 3, or 5 (landmark).</div>

Cardiology Research and Practice

fig1

Figure 1

Figure 1: Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent 

Figure 1 | Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent 